NeuroPace Inc. (NPCE) Insider Trading

Last 12 months

Insiders sold $399k and bought nothing on the open market.

All of the selling was scheduled in advance under 10b5-1 plans. The last open-market buy by an executive or director was in Apr 2021.

Net open-market

−$399k

0 buys · 1 sale

Under a 10b5-1 plan

100%

of the value sold

Insiders who bought / sold

0 / 1

executives and directors

Last open-market buy

Apr 2021

Apr 21, 2021

Get an email when NPCE's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Dec 15, 2025	Martha Morrell CHIEF MEDICAL OFFICER	Sold10b5-1 plan	25,000	$15.97	$399k	34%	Form 4
May 14, 2025	Orbimed Advisors LLC Large holder	SoldNo plan 2 parts	168,136	$15.85 average	$2.67M	4.9%	Form 4
Feb 21, 2025	Martha Morrell CHIEF MEDICAL OFFICER	Sold10b5-1 plan	78,334	$13.72	$1.07M	49%	Form 4
Feb 20, 2025	KCK Ltd. Large holder	SoldNo plan	5,270,845	$9.40	$49.5M	100%	Form 4
Jan 29, 2025 – Jan 30, 2025	Martha Morrell CHIEF MEDICAL OFFICER	Sold10b5-1 plan 2 parts	300	$15.00 average	$5k	0.3%	Form 4
Jan 24, 2025	Martha Morrell CHIEF MEDICAL OFFICER	Sold10b5-1 plan	3,200	$15.01	$48k	3.5%	Form 4
Oct 23, 2024 – Oct 25, 2024	KCK Ltd. Large holder	SoldNo plan 2 parts	224,138	$5.45 average	$1.22M	4.1%	Form 4

Dec 15, 202510b5-1 plan
Martha Morrell
CHIEF MEDICAL OFFICER · sold 25,000 at $15.97
$399k
34% of stake
May 14, 2025No plan
Orbimed Advisors LLC
Large holder · sold 168,136 at avg $15.85
$2.67M
4.9% of stake
Feb 21, 202510b5-1 plan
Martha Morrell
CHIEF MEDICAL OFFICER · sold 78,334 at $13.72
$1.07M
49% of stake
Feb 20, 2025No plan
KCK Ltd.
Large holder · sold 5,270,845 at $9.40
$49.5M
100% of stake
Jan 29, 2025 – Jan 30, 202510b5-1 plan
Martha Morrell
CHIEF MEDICAL OFFICER · sold 300 at avg $15.00
$5k
0.3% of stake
Jan 24, 202510b5-1 plan
Martha Morrell
CHIEF MEDICAL OFFICER · sold 3,200 at $15.01
$48k
3.5% of stake
Oct 23, 2024 – Oct 25, 2024No plan
KCK Ltd.
Large holder · sold 224,138 at avg $5.45
$1.22M
4.1% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch NPCE, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Surgical & Medical Instruments & Apparatus

MHUAFMeihua International Medical Technologies Co., Ltd.

XTNTXtant Medical Holdings Inc.

KMTSKestra Medical Technologies, Ltd.

OSUROrasure Technologies Inc.

DCTHDelcath Systems Inc.

LUNGPulmonx Corporation

BBNXBeta Bionics Inc.

IRMDIradimed Corp

Spot a number that looks wrong? Check it in NPCE's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing NPCE

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.